| 14.95 |  +0.02 / +0.13% |
Data as of 4:00pm ET | Day’s Change |
| 14.95 |  0.00 / 0.00% |
Volume: 2.4K |
| BSX Entangled in Patent Issues - Analyst Blog May 22 / Zacks.com | Alleged Patent Infringement by BSX - Analyst Blog May 17 / Zacks.com |
| VASC July Options Begin Trading May 20 / TheStreet.com |
| Previous close | 14.93 |
| Today’s open | 14.78 |
| Day’s range | 14.77 - 15.07 |
| Volume | 53,417 |
| Average volume (3 months) | 66,151 |
| Market cap | $246.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +5.26% |
| Earnings growth (this year) | +8.61% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +9.37% |
| P/E ratio | 24.1 |
| Price/Sales | 2.57 |
| Price/Book | 3.18 |
| Today’s change | Today’s % change | |
|---|---|---|
| DSCIDerma Sciences Inc | +0.05 | +0.36% |
| RTIXRTI Biologics Inc | +0.05 | +1.23% |
| ATECAlphatec Holdings In... | +0.03 | +1.57% |
| ZLTQZELTIQ Aesthetics In... | +0.04 | +0.79% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.17 |
| Annual revenue (last year) | $98.4M |
| Annual profit (last year) | $9.9M |
| Net profit margin | 10.07% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Howard C. Root |
Senior Vice President- Operations Charmaine Sutton |
Corporate headquarters Minneapolis, Minnesota |
.
